Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04312048
Other study ID # 00249
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date April 15, 2020
Est. completion date November 30, 2020

Study information

Verified date January 2021
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to evaluate the efficacy of isosorbide mononitrate vaginal administration in reducing pain during copper IUD insertion in nulliparous women


Recruitment information / eligibility

Status Completed
Enrollment 110
Est. completion date November 30, 2020
Est. primary completion date October 25, 2020
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - nulliparous women requesting copper IUD device insertion Exclusion Criteria: - parous women, contraindications to IUD insertion, allergy or contraindication to isosorbide mononitrate, uterine anomaly

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Isosorbide mononitrate
one tablet of Isosorbide Mononitrate (40 mg) vaginally 3 hours prior to copper IUD insertion
placebo
one tablet of placebo vaginally 3 hours prior to copper IUD insertion

Locations

Country Name City State
Egypt Ahmed Samy Giza

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary pain during IUD insertion intensity of patient-perceived pain at time of IUD insertion, using a visual analog scale. The VAS scale is graded from 0 to 100 on a 100 mm horizontal straight line, where 'zero' corresponds to no pain at all, and '100' to the worst possible pain imaginable. 5 minutes
Secondary duration of IUD insertion duration of IUD insertion from speculum in to speculum out 5 minutes
See also
  Status Clinical Trial Phase
Completed NCT04079140 - Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion Phase 4
Not yet recruiting NCT04301349 - Dinoprostone vs Misoprostol Before LNG-IUD Insertion Phase 3
Recruiting NCT06335823 - Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology N/A
Completed NCT03499743 - Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD. N/A